This trial is testing whether oral vitamin A supplementation can improve night time and peripheral vision in people with choroideremia, a disorder that causes progressive vision loss and eventual blindness.
3 Primary · 10 Secondary · Reporting Duration: Measurements at 0, 4, and 8 months. The 0 months measurement will serve as the baseline. The 4 month measurement will assess change due to vitamin A supplementation. The 8 month measurement will assess reversal of this change following washout period
10 Total Participants · 1 Treatment Group
Primary Treatment: Vitamin A palmitate · No Placebo Group · N/A
Age Any Age · Male Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: